Masaomi Nangaku
Overview
Explore the profile of Masaomi Nangaku including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
731
Citations
11534
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hashiba T, Yamahara H, Hirakawa Y, Yano Y, Yamada Y, Hara R, et al.
Nephrology (Carlton)
. 2025 Mar;
30(3):e70020.
PMID: 40083095
Recent progress in gas-sensing technology has enabled the rapid collection and highly sensitive analysis of skin gases associated with body odour. Skin gases can be collected less invasively, more continuously,...
2.
Sankoda A, Nagae Y, Waki K, Sze W, Oba K, Mieno M, et al.
JMIR Diabetes
. 2025 Mar;
10:e72076.
PMID: 40053736
[This corrects the article DOI: 10.2196/42607.].
3.
Nishima N, Hamasaki Y, Kwoun G, Hirakawa Y, Chiba A, Horiguchi Y, et al.
Intern Med
. 2025 Feb;
PMID: 39971294
Post-transplant lymphoproliferative disorder (PTLD) affects from 0.8-2.5% of kidney transplant patients, with peaks in incidence within 1 year and 10-14 years post-transplant. Very late-onset PTLD (VL-PTLD) can occur over 10...
4.
Hidaka N, Oyama Y, Koga M, Kondo N, Yasunaga Y, Shimakura T, et al.
JBMR Plus
. 2025 Feb;
9(3):ziaf010.
PMID: 39963340
Excess fibroblast growth factor 23 (FGF23), a mature osteocyte-derived phosphaturic hormone, causes chronic hypophosphatemic osteomalacia in adults. This rare condition was recently reported in 2 alcoholic patients, with marked improvement...
5.
Imaizumi T, Komaba H, Hamano T, Nangaku M, Murotani K, Hasegawa T, et al.
Clin Kidney J
. 2025 Feb;
18(2):sfae398.
PMID: 39950153
Background: The slope of estimated glomerular filtration rate (eGFR) is a promising surrogate endpoint in patients with chronic kidney disease (CKD). However, current evidence is mainly derived from Western populations...
6.
Kelly D, Jones E, Barday Z, Arruebo S, Caskey F, Damster S, et al.
PLOS Glob Public Health
. 2025 Feb;
5(2):e0004268.
PMID: 39928669
A core feature of universal health coverage is equitable access to affordable care not exposing people to financial hardship. This study aims to provide a global overview on availability and...
7.
Mizuta M, Nishi H, Odawara M, Oda Y, Nangaku M
Ann Clin Epidemiol
. 2025 Feb;
7(1):10-16.
PMID: 39926272
Background: Polycythemia often develops in the highland areas. However, it remains to be clarified whether blood hemoglobin levels in the general population are affected by elevations above sea level of...
8.
Agarwal R, Green J, Heerspink H, Mann J, McGill J, Mottl A, et al.
Nephrol Dial Transplant
. 2025 Feb;
PMID: 39916475
Background And Hypothesis: Finerenone, a selective nonsteroidal MRA, and SGLT2is both reduce CKD progression and improve kidney/CV outcomes. The CONFIDENCE study (NCT05254002; EudraCT 2021-003037-11) hypothesis is that early combination of...
9.
Jimba T, Kaneko H, Suzuki Y, Okada A, Azegami T, Ko T, et al.
Eur Heart J Cardiovasc Pharmacother
. 2025 Feb;
11(2):155-163.
PMID: 39895498
Aims: To investigate the clinical significance of the modification of the kidney protective effects of sodium-glucose cotransporter-2 (SGLT2) inhibitors by baseline body mass index (BMI). Methods And Results: We included...
10.
Sugawara Y, Hirakawa Y, Iwagami M, Inokuchi R, Wakimizu R, Nangaku M
J Med Internet Res
. 2025 Jan;
27:e67929.
PMID: 39889298
Background: Telemedicine involves medical, diagnostic, and treatment-related services using telecommunication technology. Not only does telemedicine contribute to improved patient quality of life and satisfaction by reducing travel time and allowing...